Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73,307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non-Small Cell Lung Cancer Patients.
Zhou X, Zhou L, Yao Z, Huang M, Gong Y, Zou B, Zhu J, Liu Y, Peng F, Zhang Y, Yu M, Li Y, Na F, Wu Y, Kang K, Xiu W, Zhang X, Zhou L, Xu Y, Wang J, Wang Y, Yang X, Wu Y, Li R, Zhang Y, Yang Z, Zhou Z, Bai J, Yi X, Tong R, Yin L, Chen C, Niedermann G, Lu Y, Xue J. Zhou X, et al. Among authors: xu y. Clin Cancer Res. 2023 Oct 13;29(20):4098-4108. doi: 10.1158/1078-0432.CCR-23-0315. Clin Cancer Res. 2023. PMID: 37581611
Pericardial irradiation dose may be strongly associated with grade 4 lymphopenia and affect prognosis in patients with locally advanced esophageal cancer receiving definitive concurrent chemoradiotherapy.
Chen X, Tian X, Zhang X, Deng Q, Wang M, Zhou X, Xu Y, Zhou L, Zou B, Liu Y, Ao R, Lu Y, Gong Y. Chen X, et al. Among authors: xu y. Thorac Cancer. 2023 Sep;14(27):2735-2744. doi: 10.1111/1759-7714.15057. Epub 2023 Jul 30. Thorac Cancer. 2023. PMID: 37519061 Free PMC article.
Involved-field irradiation or elective-nodal irradiation in neoadjuvant chemo-radiotherapy for locally-advanced esophageal cancer: comprehensive analysis for dosimetry, treatment-related complications, impact on lymphocyte, patterns of failure and survival.
Chen X, Zhang Y, Zhou X, Wang M, Na F, Zhou L, Xu Y, Zou B, Xue J, Liu Y, Gong Y. Chen X, et al. Among authors: xu y. Front Oncol. 2023 Oct 10;13:1274924. doi: 10.3389/fonc.2023.1274924. eCollection 2023. Front Oncol. 2023. PMID: 37886166 Free PMC article.
Discovery of (R)-4-(8-methoxy-2-methyl-1-(1-phenylethy)-1H-imidazo[4,5-c]quinnolin-7-yl)-3,5-dimethylisoxazole as a potent and selective BET inhibitor for treatment of acute myeloid leukemia (AML) guided by FEP calculation.
Yu S, Zhang Y, Yang J, Xu H, Lan S, Zhao B, Luo M, Ma X, Zhang H, Wang S, Shen H, Zhang Y, Xu Y, Li R. Yu S, et al. Among authors: xu h, xu y. Eur J Med Chem. 2024 Jan 5;263:115924. doi: 10.1016/j.ejmech.2023.115924. Epub 2023 Nov 7. Eur J Med Chem. 2024. PMID: 37992518
73,307 results
You have reached the last available page of results. Please see the User Guide for more information.